Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Warrant extension implies 50-cents+ in two years

<< Previous

Bullboard Posts

Next >>

Post by newdaydawningon Jan 09, 2021 2:47pm

264 Views

Post# 32261663

Warrant extension implies 50-cents+ in two years

I believe that target is imminently doable if we accomplish just two things:

1. We get BTD for NMIBC supported by good outcomes from the US trials;

2 We get promising results from the early human trials showing TLD-1433's efficacy and safety for the treatment of - and protection against - Covid-19 and every other nasty virus.

Considering today's SP, a move to 50 cents minimum implies a return of 177% over 2 years!

IMO, the upside potential for TLT far outweighs the downside risk.

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week